Tradestie Institutional Equity Comparison Engine

VCYT vs MYGN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

VCYT Overall Edge

VCYT Captures Institutional Edge (2โ€“2 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Veracyte, Inc. (VCYT) driven by superior Valuation, Growth & Margin while MYGN counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, VCYT trades at 15.3x Forward P/E with 15.0% operating margin (+15.1% YoY revenue) versus MYGN at 54.0x Forward P/E and -13.3% operating margin (-1.5% YoY). In options structure, VCYT sits in BREAKDOWN (47th %ile IV; Dealer Gamma Walls on Pro) against MYGN sits in SURGE (22nd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner VCYT
VCYT 15.3x vs MYGN 54.0x Fwd P/E
Growth & Margin Winner VCYT
Op Margin 15.0% vs -13.3% ยท YoY +15.1% vs -1.5%
Momentum & Technical Winner MYGN
1Y -39.8% vs -12.3% ยท 52W Pos 5% vs 53%
Options & Structure Winner MYGN
BREAKDOWN (47th %ile IV) vs SURGE (22nd %ile IV)
VCYT NASDAQ
Veracyte, Inc.
Services-Medical Laboratories
$24.01
-1.32% 1D
Market Cap $2.0B
1M Return -44.32%
1Y Return -39.78%
Forward P/E 15.3x
Unified AI Score
49.1 / 100 HOLD
Tech 55.0 Fund 56.0 Flow 57.0 Mom 55.0
MYGN NASDAQ
Myriad Genetics Inc
In Vitro & In Vivo Diagnostic Substances
$5.57
-1.59% 1D
Market Cap $542.9M
1M Return +39.95%
1Y Return -12.28%
Forward P/E 54.0x
Unified AI Score
46.2 / 100 HOLD
Tech 30.0 Fund 43.0 Flow 56.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: VCYT -39.78% MYGN -12.28% Spread: +27.5 pp (MYGN Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period VCYT Revenue MYGN Revenue VCYT Op. Margin MYGN Op. Margin Margin Edge
FY2018 $90M $740M -24.2% 16.4% MYGN
FY2019 $120M $850M -12.6% 0.9% MYGN
FY2020 $120M $560M -30.1% -52.0% VCYT
FY2021 $220M $690M -37.3% -27.6% MYGN
FY2022 $300M $680M -13.9% -20.7% VCYT
FY2023 $360M $750M -23.8% -34.2% VCYT
FY2024 $450M $840M 3.6% -14.7% VCYT
FY2025 $520M $820M 11.2% -47.0% VCYT

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: VCYT (8) vs MYGN (2)
Institutional Metric VCYT MYGN Criterion Row Winner
Market Capitalization Scale $2.0B $542.9M Larger Scale VCYT
Trailing P/E Ratio Valuation 15.8x 54.0x Lower Multiple VCYT
Forward P/E Ratio Valuation 15.3x 54.0x Lower Multiple VCYT
Revenue Growth (YoY) Growth +15.1% -1.5% Higher Growth VCYT
Operating Margin (TTM) Profitability 15.0% -13.3% Higher Margin VCYT
Net Profit Margin Profitability 21.8% -16.1% Higher Margin VCYT
Return on Equity (ROE) Capital Efficiency 9.4% -40.2% Higher ROE VCYT
52-Week Range Position Momentum 5% ($22โ€“$61) 53% ($3โ€“$8) Stronger Trend MYGN
Beta / 30D Volatility Risk Regime 3.01ฮฒ ยท 199% Vol 0.68ฮฒ ยท 122% Vol Lower Realized Risk MYGN
Unified Institutional Score Composite Signal 49.1 / 100 (HOLD) 46.2 / 100 (HOLD) Higher Composite VCYT

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full VCYT vs MYGN Buy Guide
VCYT BREAKDOWN
99d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 47th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live VCYT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
MYGN SURGE
12d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 22nd %ile
IV Regime Compressed (<25th %ile)
Live MYGN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither VCYT nor MYGN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.